US2005038354A1PendingUtilityA1

Method for determining attention deficit hyperactivity disorder (ADHD) medication dosage and for monitoring the effects of (ADHD) medication

Priority: May 25, 2001Filed: May 28, 2004Published: Feb 17, 2005
Est. expiryMay 25, 2021(expired)· nominal 20-yr term from priority
A61B 3/113G16H 15/00A61B 5/168A61B 5/0002A61B 5/01A61B 5/726A61B 5/7257
45
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method for determining the appropriate dosage of a medication to treat Attention Deficit Hyperactivity Disorder (ADHD) in an individual who has ADHD comprising: sampling the peripheral skin temperature of a human subject during a predetermined time interval when the subject is in an inactive state to provide sampled peripheral skin temperature data; analyzing the sampled peripheral skin temperature data for a pre-selected parameter to determine whether the pre-selected parameter has a value indicative of ADHD; and determining the proper dosage of a medication to treat ADHD based upon the determined value of the pre-selected parameter. At a time subsequent to administering the dosage, it is determined if a previously administered dosage of a medication is effective at removing the effects of ADHD as measured by this pre-selected parameter.

Claims

exact text as granted — not AI-modified
1 - 19 . Cancelled.  
     
     
         20 . A method of diagnosing a disorder comprising: 
 sampling the peripheral skin temperature of a human subject during a predetermined time interval when the subject is in an inactive state to provide sampled peripheral skin temperature data; and    analyzing the sampled peripheral skin temperature data for a pre-selected parameter, to determine whether said pre-selected parameter has a value indicative of a disorder characterized by the symptoms of inattention, hyperactivity, and impulsivity.    
     
     
         21 . The method of  claim 20  wherein said data is processed with a fourier transform algorithm to produce frequency and phase data.  
     
     
         22 . The method of  claim 20  wherein said data is processed with a wavelet transform algorithm to produce frequency and phase data.  
     
     
         23 . An apparatus for diagnosing a disorder comprising: 
 a device for sampling the peripheral skin temperature of a human subject during a predetermined time interval when the subject is in an inactive state to provide sampled peripheral skin temperature data; and    an analyzer for analyzing the sampled peripheral skin temperature data for a pre-selected parameter to determine whether said pre-selected parameter has a value indicative of a disorder characterized by the symptoms of inattention, hyperactivity, and impulsivity.    
     
     
         24 . The method of  claim 23  wherein said data is processed with a fourier transform algorithm to produce frequency and phase data.  
     
     
         25 . The method of  claim 23  wherein said data is processed with a wavelet transform algorithm to produce frequency and phase data.  
     
     
         26 . A method for determining the appropriate dosage of a medication comprising: 
 measuring the stress of a human subject by sampling the peripheral skin temperature of a human subject during a predetermined time interval when the subject is in an inactive state to provide sampled peripheral skin temperature data;    analyzing the sampled peripheral skin temperature data for a pre-selected parameter to determine whether said pre-selected parameter has a value indicative of a disorder characterized by the symptoms of inattention, hyperactivity, and impulsivity; and    determining the proper dosage of a medication to treat said disorder based upon said determined value of said pre-selected parameter; and    at a time subsequent to administering said dosage, determining if the administered dosage of medication is actually effective at removing the symptoms of said disorder as measured by said pre-selected parameter.

Join the waitlist — get patent alerts

Track US2005038354A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.